NCT00003543View on ClinicalTrials.gov

Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

monoclonal antibody A33

DRUG

carmustine

DRUG

fluorouracil

DRUG

streptozocin

DRUG

vincristine sulfate

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003543 - Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | Biotech Hunter | Biotech Hunter